KRTX

Karuna Therapeutics Stock Price

97.99
-0.88 (-0.89%)
Upgrade to Real-Time
Afterhours (Closed)
97.99
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Karuna Therapeutics Inc KRTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.88 -0.89% 97.99 18:00:45
Open Price Low Price High Price Close Price Previous Close
99.23 95.95 99.23 97.99 98.87
Bid Price Ask Price Spread News
44.44 105.00 60.56 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,583 58,529 $ 97.86 $ 5,727,369 157,720 52.62 - 123.73
Last Trade Time Type Quantity Stock Price Currency
16:00:38 3 $ 97.99 USD

Karuna Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.63B 26.81M 12.16M $ - $ - -145.98 -142.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 62.19k 0.90%

more financials information »

Karuna Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical KRTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week99.99101.9795.0398.72153,594-2.00-2.0%
1 Month81.00109.9977.8597.27183,61616.9920.98%
3 Months73.15109.9969.5885.37176,59424.8433.96%
6 Months88.69123.7369.5890.26194,7799.3010.49%
1 Year87.41123.7352.6284.96290,77710.5812.1%
3 Years18.50152.0011.2482.53308,12779.49429.68%
5 Years18.50152.0011.2482.53308,12779.49429.68%

Karuna Therapeutics Description

Karuna Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical need. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues.


Your Recent History
NASDAQ
KRTX
Karuna The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.